Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Clinical trial NCT06824168 · RECRUITING
Trial details
- NCT number
- NCT06824168
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2028-06-06
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.